{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Sugar Land",
      "state": "TX",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "68304",
      "recalling_firm": "Healix Infusion Therapy, Inc.",
      "address_1": "1075 W Park One Dr",
      "address_2": "",
      "postal_code": "77478-2576",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Texas",
      "recall_number": "D-1422-2014",
      "product_description": "BUPivacaine HCl 0.25% Preservative Free (2.5 mg/mL) 500 mL in On-Q C-bloc (2-14 mL/hr) bag, Healix Infusion Therapy, Inc., 1075 West Park One Drive, Suite 200, Sugar Land, Texas  77478, NDC 75901-7210-53.",
      "product_quantity": "10 bags",
      "reason_for_recall": "Presence of Particulate Matter:  The bupivacaine HCl injection used to compound this lot of BUPivacaine HCl 0.25% Preservative Free 500 mL in On-Q C-bloc was recalled by the supplier due to a customer complaint of visible particles embedded in the glass vial.",
      "recall_initiation_date": "20140213",
      "center_classification_date": "20140707",
      "termination_date": "20160216",
      "report_date": "20140716",
      "code_info": "Lot #: 6156-0, Exp 03/07/14",
      "more_code_info": ""
    }
  ]
}